From 1 September 2023, many patients living with an ongoing health condition who are stable on their current treatment will be able to receive twice the medication for the cost of a single prescription.
This will apply to more than 300 common medicines listed on the pharmaceutical benefits scheme and will be implemented in three stages over 12 months.
Stage one includes 92 medicines and represents roughly one third of all the medicines eligible for 60-day prescriptions.
See the list of the stage one medicines. The order of medicines to be made available in stage two and three is still being finalised.
The full list of eligible medicines that have been reviewed and recommended by PBAC as suitable for 60-day prescribing is available on the medicine list for increased dispensing quantities.
Doctors will have the option to prescribe medicines for either 30 or 60-day prescriptions, according to their professional clinical judgement.
More information is available here